Focus topics

Brii Biosciences’ Covid drug approved

China’s National Medical Products Administration has approved a COVID-19 antibody treatment. The drug manufactured by Brii Biosciences showed an 80 percent reduction in hospitalizations and deaths, according to the Beijing-based company. More details on the effectiveness against the Omicron variant are expected in two weeks.

Continue reading now

Get 30 days of free access to the Professional Briefing to read these and more quality news every day.

Are you already a guest at the China.Table? Log in now


    Production at Apple and Tesla remains impaired
    EU Greens propose Taiwan treaty
    Jiang Zemin cremated
    Billionaire plans Hong Kong Formula One team